Lobe Sciences Ltd.
LOBEF
$0.0407
$0.004813.37%
OTC PK
| 05/31/2025 | 02/28/2025 | 11/30/2024 | 08/31/2024 | 05/31/2024 | |
|---|---|---|---|---|---|
| Net Income | -123.53% | -10.85% | -39.90% | -100.21% | -36.17% |
| Total Depreciation and Amortization | -- | -- | -- | -100.00% | 61.72% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 68.11% | 145.93% | 341.03% | 1,187.23% | -249.37% |
| Change in Net Operating Assets | 191.07% | -66.72% | -33.98% | -49.73% | -71.65% |
| Cash from Operations | -22.85% | -1,001.29% | -154.61% | 97.78% | -160.92% |
| Capital Expenditure | -- | -- | -- | -- | -- |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | -- |
| Cash from Investing | -- | -- | -- | -- | -- |
| Total Debt Issued | 2,364.48% | -- | -- | -- | 404.18% |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | -- | -- | -- | -- | -- |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | 2,288.46% | -- | -- | 1,861.90% | 503.16% |
| Foreign Exchange rate Adjustments | 206.35% | -478.95% | 2,700.00% | -666.67% | 6,200.00% |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 31,288.89% | 97.09% | -124.93% | 132.98% | -95.81% |